31 Jan 2017 16:39
Venture Life Group plc
("Venture Life" or the "Group")
Investor Day presentation now available
Venture Life (AIM: VLG), the international consumer self-care group focused on developing, manufacturing and commercialising products for the ageing population, announces that the presentations delivered on Thursday 26 January 2017, along with the recorded audio, are now available to view on the Group's website:
http://www.venture-life.com/node/328
For further information please contact:
Venture Life Group PLC | +44 (0) 1344 742870 | |
Jerry Randall, Chief Executive Officer |
| |
|
| |
Panmure Gordon (UK) Limited (Nominated Adviser and Joint Broker) | +44 (0) 20 7886 2500 | |
Freddy Crossley/Peter Steel/Duncan Monteith (Corporate Finance) |
| |
Tom Salvesen (Corporate Broking) |
| |
| ||
Turner Pope Investments (TPI) Ltd (Joint Broker) | +44 (0) 20 3621 4120 | |
James Pope/Ben Turner |
| |
| ||
Walbrook PR | venturelife@walbrookpr.com or +44 (0) 20 7933 8780 | |
Paul McManus/Anna Dunphy | +44 (0) 7980 541 893 / +44 (0) 7876 741 001 | |
About Venture Life (www.venture-life.com)
Venture Life is an international consumer self-care company focused on developing, manufacturing and commercialising products for the ageing population. The Group's product range and pipeline currently includes the UltraDEX oral care products range, food supplements for lowering cholesterol and maintaining brain function, dermo-cosmetics for addressing the signs of ageing, and medical devices for improving minor aches and pains, dry eyes and itchy skin.
The products, which typically are recommended by pharmacists or healthcare practitioners, are available primarily through pharmacies supplied by the Group's international distribution partners.
Through its Development & Manufacturing business, Biokosmes, the Group also provides development and manufacturing services to companies in the medical devices and cosmetic sectors.
Venture Life (VLG)